Streamline Health Solutions
STRM
STRM was delisted on the 11th of August, 2025.
37 hedge funds and large institutions have $34.1M invested in Streamline Health Solutions in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more capital invested
Capital invested by funds: $28.3M → $34.1M (+$5.72M)
0.12% more ownership
Funds ownership: 2.08% → 2.2% (+0.12%)
0% more funds holding
Funds holding: 37 → 37 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$641K |
| 2 |
TC
TownSquare Capital
Provo,
Utah
|
+$355K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$350K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$211K |
| 5 |
SRAM
Spouting Rock Asset Management
Bryn Mawr,
Pennsylvania
|
+$71.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$34K |
| 2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$33.1K |
| 3 |
VF
Virtu Financial
New York
|
-$22K |
| 4 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$21.4K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$20.4K |
STRM Hedge Fund Activity: Q1 2023 in Review
37 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q1 2023, worth a combined $34.1M — up 20% from $28.3M a quarter earlier.
Fund positioning in STRM was balanced in Q1 2023: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 6 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $641K. The largest seller was HRT Financial, exiting entirely with an estimated $34K sold.
- 37 institutional investors held Streamline Health Solutions (STRM) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $34.1M of Streamline Health Solutions stock for Q1 2023, up 20% quarter-over-quarter.
- 5 funds opened new Streamline Health Solutions positions in Q1 2023 and 5 closed out, a net change of 0 holders.
- The largest Streamline Health Solutions buyer in Q1 2023 was UBS Group, an estimated $641K added.
- The largest Streamline Health Solutions seller in Q1 2023 was HRT Financial, an estimated $34K sold.
Based on aggregated 13F filings for Q1 2023.